Versatope Therapeutics has been awarded a Phase 1 Small Business and Innovation Award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to develop a novel vaccine ...
According to Centers for Disease Control and Prevention, influenza vaccines were overall 29 per cent effective during the 2018–2019 influenza season due to the emergence of new, late season viral strains.